| Literature DB >> 32859864 |
Kirti Sachdev1, Sumita Agrawal2, Pranav Ish3, Nitesh Gupta3, Kapil Raheja4.
Abstract
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been predominantly a respiratory manifestation. Currently, with evolving literature, neurological signs are being increasingly recognized. Studies have reported that SARS-CoV-2 affects all aspects of the nervous system including the central nervous system (CNS), peripheral nervous system (PNS) and the muscular system as well. Not all patients have reverse transcription-polymerase chain reaction positive for the virus in the cerebrospinal fluid, and diagnosing the association of the virus with the myriad of neurological manifestations can be a challenge. It is important that clinicians have a high-index of suspicion for COVID-19 in patients presenting with new-onset neurological symptoms. This will lead to early diagnosis and specific management. Further studies are desired to unravel the varied neurological manifestations, treatment, outcome and long-term sequel in COVID-19 patients.Entities:
Keywords: COVID-19; CSF; SARS-CoV-2; encephalopathy; intracranial pressure; ischaemic stroke; nervous system diseases; neuronal cells; venous thromboembolism
Mesh:
Year: 2020 PMID: 32859864 DOI: 10.4103/ijmr.IJMR_1395_20
Source DB: PubMed Journal: Indian J Med Res ISSN: 0971-5916 Impact factor: 2.375